Updated Labeling for Menopausal Hormone Therapy
Martin A. Makary, Christine Nguyen, Tracy Beth Høeg, George F. Tidmarsh
Abstract
This Viewpoint describes the US Food and Drug Administration’s intended label updates and removal of black box warnings for menopausal hormone therapy based on current evidence.
Topics & Concepts
MedicineHormone therapyMEDLINEFood and drug administrationInternal medicineHormoneMenopauseBioinformaticsHormone replacement therapy (female-to-male)GynecologyPharmacotherapyOncologyEndocrinologyPhysiologyDrugEstrogen replacement therapyClinical trialMenopause: Health Impacts and TreatmentsEstrogen and related hormone effectsSex and Gender in Healthcare